ELANCO ANIMAL HLTH ($ELAN) posted quarterly earnings results on Wednesday, November 5th. The company reported earnings of $0.19 per share, beating estimates of $0.13 by $0.06. The company also reported revenue of $1,137,000,000, beating estimates of $1,113,532,051 by $23,467,949.
You can see Quiver Quantitative's $ELAN stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
ELANCO ANIMAL HLTH Hedge Fund Activity
We have seen 211 institutional investors add shares of ELANCO ANIMAL HLTH stock to their portfolio, and 178 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- FMR LLC added 11,024,724 shares (+20.5%) to their portfolio in Q2 2025, for an estimated $157,433,058
- CITADEL ADVISORS LLC added 6,834,414 shares (+99.5%) to their portfolio in Q2 2025, for an estimated $97,595,431
- UBS GROUP AG added 6,066,677 shares (+136.6%) to their portfolio in Q2 2025, for an estimated $86,632,147
- CLEARBRIDGE INVESTMENTS, LLC added 5,397,434 shares (+inf%) to their portfolio in Q2 2025, for an estimated $77,075,357
- MORGAN STANLEY added 5,277,645 shares (+112.4%) to their portfolio in Q2 2025, for an estimated $75,364,770
- FULLER & THALER ASSET MANAGEMENT, INC. added 5,102,701 shares (+inf%) to their portfolio in Q2 2025, for an estimated $72,866,570
- MILLENNIUM MANAGEMENT LLC added 3,836,052 shares (+inf%) to their portfolio in Q2 2025, for an estimated $54,778,822
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
ELANCO ANIMAL HLTH Congressional Stock Trading
Members of Congress have traded $ELAN stock 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $ELAN stock by members of Congress over the last 6 months:
- REPRESENTATIVE VAL T. HOYLE sold up to $15,000 on 09/23.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
ELANCO ANIMAL HLTH Analyst Ratings
Wall Street analysts have issued reports on $ELAN in the last several months. We have seen 5 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- JP Morgan issued a "Overweight" rating on 10/07/2025
- Stifel issued a "Buy" rating on 09/24/2025
- UBS issued a "Buy" rating on 08/08/2025
- Leerink Partners issued a "Outperform" rating on 07/17/2025
- William Blair issued a "Outperform" rating on 06/26/2025
To track analyst ratings and price targets for ELANCO ANIMAL HLTH, check out Quiver Quantitative's $ELAN forecast page.
ELANCO ANIMAL HLTH Price Targets
Multiple analysts have issued price targets for $ELAN recently. We have seen 5 analysts offer price targets for $ELAN in the last 6 months, with a median target of $23.0.
Here are some recent targets:
- Andrea Alfonso from UBS set a target price of $25.0 on 10/20/2025
- Chris Schott from JP Morgan set a target price of $24.0 on 10/07/2025
- Jonathan Block from Stifel set a target price of $23.0 on 09/24/2025
- David Westenberg from Piper Sandler set a target price of $18.0 on 08/11/2025
- Daniel Clark from Leerink Partners set a target price of $18.0 on 07/17/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
